Tularemia – A Review with Concern for Bioterrorism

Main Article Content

Paul Rega Michael Guinness Chistopher McMahon

Abstract

N/A

Article Details

How to Cite
REGA, Paul; GUINNESS, Michael; MCMAHON, Chistopher. Tularemia – A Review with Concern for Bioterrorism. Medical Research Archives, [S.l.], v. 5, n. 8, aug. 2017. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/1389>. Date accessed: 28 feb. 2024.
Keywords
medical, medicine,research,pharmacology
Section
Research Articles

References

1. Adalja A. A., Toner E., Inglesby T.V. Clinical Management of Potential Bioterrorism-Related Conditions (2015). N Engl J Med, 372 (10), 954-962.
2. Altizer, S, Ostfeld, R.S., Johnson, P.T.J., et al. Climate Change and Infectious Diseases: From Evidence to a Predictive Framework. Science 02 Aug 2013: 514-519.
3. Aquino, L. L., & Wu, J. J. (2011). Cutaneous manifestations of category A bioweapons. Journal of the American Academy of Dermatology, 65(6), 1213 e1211-1213 e1215. doi: 10.1016/j.jaad.2010.08.040

4. Avery, F. W., & Barnett, T. B. (1967). Pulmonary tularemia. A report of five cases and consideration of pathogenesis and terminology. American Review of Respiratory Disease, 95(4), 584-591.
5. Bork, C. E. and Rega, P. P. (2012), An Assessment of Nurses’ Knowledge of Botulism. Public Health Nurs., 29: 168–174. doi:10.1111/j.1525-1446.2011.00988.x
6. Bush, L.M., Abrams, B.H., Beall, A., Johnson, C.C. Index Case of Fatal Inhalational Anthrax Due to Bioterrorism in the United States. N Engl J Med 2001; 345:1607-1610; November 29, 2001. DOI: 10.1056/NEJMoa012948
7. Center for Biosecurity of UPMC. Francisella tularensis (Tularemia) (2011). Updated 10/13/2011. www.upmc-biosecurity.org.
8. Center for Infectious Disease Research and Policy. (2010). Tularemia: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis, from http://www.cidrap.umn.edu/cidrap/content/bt/tularemia/biofacts/tularemiafactsheet.html
9. Centers for Disease Control and Prevention. (1998). Summary of notifiable diseases, United States, 1997. MMWR; Morbidity and Mortality Weekly Report, 46(54), ii-vii, 3-87.
10. Centers for Disease Control and Prevention. (2002). Tularemia--United States, 1990-2000. MMWR; Morbidity and Mortality Weekly Report, 51(9), 181-184.
11. Centers for Disease Control and Prevention. (2011, January 11, 2011). Tularemia, from http://www.cdc.gov/tularemia/
12. Centers for Disease Control and Prevention. (2016). Tularemia, from http://www.cdc.gov/tularemia/index.html
13. Centers for Disease Control and Prevention (2015). Tularemia, Signs and Symptoms. https://www.cdc.gov/tularemia/signssymptoms/index.html
14. Centers for Disease Control and Prevention. (2015). Tularemia Transmission. https://www.cdc.gov/tularemia/transmission/index.html
15. Centers for Disease Control and Prevention. (2016). Tularemia, Diagnostic Testing. https://www.cdc.gov/tularemia/clinicians/index.html.
16. Centers for Disease Control and Prevention. (2016). Tularemia, Treatment. https://www.cdc.gov/tularemia/clinicians/index.html.
17. Christopher, G. W., Cieslak, T. J., Pavlin, J. A., & Eitzen, E. M., Jr. (1997). Biological warfare. A historical perspective. JAMA, 278(5), 412-417.
18. Dahlstrand, S., Ringertz, O., & Zetterberg, B. (1971). Airborne tularemia in Sweden. Scandinavian Journal of Infectious Diseases, 3(1), 7-16.
19. Darling, R. G., & Catlett, C. L. (2002). Threats in bioterrorism I: CDC catagory A agents. Emergency Medicine Clinics of North America, 20, 273-309.
20. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., . . . Working Group on Civilian, B. (2001). Tularemia as a biological weapon: Medical and public health management. JAMA, 285(21), 2763-2773.
21. Ellis, J., Oyston, P. C., Green, M., & Titball, R. W. (2002). Tularemia. Clinical Microbiology Reviews, 15(4), 631-646.
22. Evans, M. E., & Friedlander, A. M. (1997). Textbook of military medicine: Medical aspects of chemical and biological warfare. Washington, DC: Office of the Surgeon General, Department of the Army, United States of America.
23. Evans, M. E., Gregory, D. W., Schaffner, W., & McGee, Z. A. (1985). Tularemia: A 30-year experience with 88 cases. Medicine, 64(4), 251-269.
24. FDA. Emergency Use of an Investigational Drug or Biologic. https://www.fda.gov/RegulatoryInformation/Guidances/ucm126491.htm. 2016.
25. Feldman, K. A., Enscore, R. E., Lathrop, S. L., Matyas, B. T., McGuill, M., Schriefer, M. E., . . . Hayes, E. B. (2001). An outbreak of primary pneumonic tularemia on Martha's Vineyard. New England Journal of Medicine, 345(22), 1601-1606. doi: 10.1056/NEJMoa011374
26. FEMA/USACE (2010). IS-26: Guide to Points of Distribution. https://training.fema.gov/is/courseoverview.aspx?code=IS-26. Accessed 5/29/17
27. Gimenez-Garcia, R.., Serna de Frutos, M., Gil Dominguez, M., Villalba Cabezon G. (2016). J Infect Dis Ther. 4:3. Dx.doi.org/10.4172/2332-0877.1000282.
28. GlobalSecurity.org. (2011, July 24, 2011). Weapons of mass destruction (WMD), from http://www.globalsecurity.org/wmd/intro/bio-tularemia.htm
29. Holland, K.M., Rosa S.J., Hazlett K.R.O. (2016). Francisella tularensis – Immune Cell Activator, Suppressor, or Stealthy Evader: The Evolving View from the Petri Dish. J Bioterr Biodef, 7(2). Doi: 10.4172/2157-2526.1000/44.
30. Jacoby I. Francisella tularensis (Tularemia) Attack in in Ciottone’s Disaster Medicine, 2e by G. R. Ciottone, P. D. Bittinger, et al (eds). November, 2015; Elsevier, Philadelphia, PA. ISBN-13: 978-0323286657.
31. Jellison, W. L., & Kohls, G. M. (1955). Tularemia in sheep and in sheep industry workers in western United States. Public Health Monograph, 28, 1-19.
32. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerging Infectious Diseases. 2001;7(6):933-944.
33. Karpoff, S. P., & Antonoff, N. I. (1936). The spread of tularemia through water, as a new factor in its epidemiology. Journal of Bacteriology, 32(3), 243-258.
34. Karwa, M., Currie, B., & Kvetan, V. (2005). Bioterrorism: Preparing for the impossible or the improbable. Critical Care Medicine, 33(1 Suppl), S75-95.
35. Lam, C, Waldhorn R, Toner, E, Inglesby T.V., O'Toole, T. (2006). The Prospect of Using
a. Alternative Medical Care Facilities in an Influenza Pandemic. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 4(4): 384-390.
https://doi.org/10.1089/bsp.2006.4.384

36. Matyas, B. T., Nieder, H. S., & Telford, S. R., 3rd. (2007). Pneumonic tularemia on Martha's Vineyard: clinical, epidemiologic, and ecological characteristics. Annals of the New York Academy of Sciences, 1105, 351-377. doi: 10.1196/annals.1409.013
37. Maurin, M. (2015). Francisella tularensis as a potential agent of bioterrorism? Expert Rev. Anti Infect. Ther. 13(2), 141-144.
38. McDade JE, Franz D. Bioterrorism as a Public Health Threat. Emerg Infect Dis. 1998;4(3):493-494. https://dx.doi.org/10.3201/eid0403.980341
39. McGovern, T. W., Christopher, G. W., & Eitzen, E. M. (1999). Cutaneous manifestations of biological warfare and related threat agents. Archives of Dermatology, 135(3), 311-322.
40. Nigrovic, L. E., & Wingerter, S. L. (2008). Tularemia. Infectious Disease Clinics of North America, 22(3), 489-504, ix. doi: 10.1016/j.idc.2008.03.004
41. Pedati, C., House, J., Hancock-Allen, J., Colton, L, et al. (2015). Notes from the Field: Increase in Human Cases of Tularemia — Colorado, Nebraska, South Dakota, and Wyoming, January–September 2015. Morbidity and Mortality Weekly Report (MMWR). December 4, 2015 / 64(47);1317-8.

42. Penn, R. L. (2012, January 17, 2012). Epidemiology, microbiology, and pathogenesis of tularemia, from http://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia
43. Roberts L. M., Wehrly T. D., Crane D.D., Bosio C. M. (2017). Expansion and retention of pulmonary CD4+ Tcells after prime boost vaccination correlates with improved longevity and strength of immunity against tularemia. Vaccine, 35, 2575-2581.
44. Saslaw, S., Eigelsbach, H. T., Prior, J. A., Wilson, H. E., & Carhart, S. (1961). Tularemia vaccine study II. Respiratory challenge. Archives of Internal Medicine, 107, 702-714.
45. Southern Illinois University School of Medicine. (2012, January 13, 2012). Tularemia: Natural disease vs. act of bioterrorism, from http://www.siumed.edu/medicine/id/tularemia.htm
46. Stuart, B., & Pullen, R. (1945a). Tularemic meningitis: Review of the literature and report of a case with postmortem observations. Archives of Internal Medicine, 76, 163-166.
47. Stuart, B., & Pullen, R. (1945b). Tularemic pneumonia: Review of American literature and report of 15 additional cases. American Journal of Medical Science, 210, 223-236.
48. Syrjala, H., Kujala, P., Myllyla, V., & Salminen, A. (1985). Airborne transmission of tularemia in farmers. Scandinavian Journal of Infectious Diseases, 17(4), 371-375.
49. Thomas, L. D., & Schaffner, W. (2010). Tularemia pneumonia. Infectious Disease Clinics of North America, 24(1), 43-55. doi: 10.1016/j.idc.2009.10.012
50. Torok TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S, A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA. 1997;278: 389–95.

Similar Articles

<< < 1 2 3 4 

You may also start an advanced similarity search for this article.